Ally Bridge Group »

Atai Life Sciences Nv shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Atai Life Sciences Nv (ATAI) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Atai Life Sciences Nv

Tip: Access up to 7 years of quarterly data

All positions including Atai Life Sciences Nv held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atai Life Sciences Nv by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $12M 2.3M 5.29

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Replimune Group Call Option (REPL)
Madrigal Pharmaceuticals (MDGL)
Compass Pathways Sponsored Ads (CMPS)
Atai Beckley Nv SHS (ATAI)
Ascendis Pharma A/s - Sponsored Adr (ASND)
Lenz Therapeutics (LENZ)
Taysha Gene Therapies Com Shs (TSHA)
Amylyx Pharmaceuticals (AMLX)
Eupraxia Pharmaceuticals (EPRX)
Praxis Precision Medicines I Com New Call Option (PRAX)
Monopar Therapeutics Com New (MNPR)
Arcutis Biotherapeutics (ARQT)
Mind Medicine Mindmed Com New (MNMD)
Tarsus Pharmaceuticals (TARS)

View all positions for Ally Bridge Group

Top funds holding Atai Life Sciences Nv

UBS Group
Adage Capital Partners GP
Morgan Stanley
Citadel Advisors
Ally Bridge Group
ARK Investment Management
T. Rowe Price Investment Management
Susquehanna International
Millennium Management
Pale Fire Capital SE
Marshall Wace
Moore Capital Management
ADAR1 Capital Management
Jpmorgan Chase & Co
Jane Street

View all funds holding Atai Life Sciences Nv